ALPHA TRIBE

Tata Chemicals LimitedImportant, 03-02-2025: Financial Result Updates

03-02-2025 | 06:28 pm

**Consolidated Financial Results Summary:**

Tata Chemicals has reported consolidated revenue from operations of ₹3,590 crore for the quarter ended December 31, 2024, reflecting a decline of 10.2% compared to ₹3,999 crore in the previous quarter. Year-to-date, total revenue is ₹11,378 crore, down from ₹11,946 crore last year, driven by a challenging market environment in basic chemistry products, despite a robust demand for specialty products which showed resilience.

The net loss for the quarter stands at ₹(21) crore, compared to a profit of ₹267 crore in Q3 last year. Year-to-date, the net profit has decreased to ₹436 crore, down from ₹1,276 crore, largely impacted by higher operational costs and exceptional items related to the cessation of production at a facility in the UK. The Earnings Per Share (EPS) is reported at ₹(2.08) for the quarter.

Operational costs increased overall, with materials consumed rising to ₹657 crore, reflecting an increase in procurement costs, while employee benefits also grew to ₹527 crore. The company managed its finance costs effectively at ₹148 crore, but elevated depreciation expenses further constrained profitability.

The balance sheet indicates a total asset position of ₹37,366 crore and a debt-equity ratio of 0.30, signalling moderate leverage. Looking ahead, Tata Chemicals appears focused on enhancing cost efficiencies and exploring market opportunities in specialty chemicals to navigate current challenges.

**Investor Insight:** Given the recent performance trends and strategic focus areas, a hold position may be prudent until further clarity on market conditions and recovery in profitability materializes.

No comments yet. Be the first to comment!

All announcements from Tata Chemicals Limited